89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
89bio reports 2021 executive compensation
By ExecPay News
Published: April 14, 2022
89bio reported fiscal year 2021 executive compensation information on April 14, 2022.
In 2021, three 89bio executives received on average a compensation package of $2.9M, a 5% increase compared to previous year.
Average pay of disclosed executives at 89bio
Rohan Palekar, Chief Executive Officer, received $4.9M in total, which increased by 1% compared to 2020. 69% of Palekar's compensation, or $3.4M, was in option awards. Palekar also received $254K in non-equity incentive plan, $565K in salary, $690K in stock awards, as well as $10K in other compensation.
Hank Mansbach, Chief Medical Officer, received a compensation package of $2M, which increased by 14% compared to previous year. 57% of the compensation package, or $1.1M, was in option awards.
Quoc Le-Nguyen, Chief Technical Operations Officer and Head of Quality, earned $1.9M in 2021, a 11% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 14, 2022.